loader
Please Wait
Applying Filters...

Approved Drug Products containing 17.alpha.-Ethynyl-19-nortestosterone listed with Health Canada. Original Data : Health Canada Website

Menu
$ API Ref.Price (USD/KG) : 3,359Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1GLENMARK PHARMACEUTICALS CANADA INC.

02 1LUPIN PHARMA CANADA LIMITED

03 1MYLAN PHARMACEUTICALS ULC

04 10PFIZER CANADA ULC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

NORETHINDRONE

Brand Name : BREVICON 1/35 TABLETS (21-DAY PACK)

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging : 21

Approval Date :

Application Number : 2189054

Regulatory Info : Prescription

Registration Country : Canada

blank

02

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

NORETHINDRONE

Brand Name : BREVICON 1/35 TABLETS (28-DAY PACK)

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging : 28

Approval Date :

Application Number : 2189062

Regulatory Info : Prescription

Registration Country : Canada

blank

03

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

NORETHINDRONE

Brand Name : SELECT 1/35 (21-DAY)

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging : 21

Approval Date :

Application Number : 2197502

Regulatory Info : Prescription

Registration Country : Canada

blank

04

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

NORETHINDRONE

Brand Name : SELECT 1/35 (28-DAY)

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging : 28

Approval Date :

Application Number : 2199297

Regulatory Info : Prescription

Registration Country : Canada

blank

05

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

NORETHINDRONE

Brand Name : BREVICON 0.5/35 TABLETS (28-DAY PACK)

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 28

Approval Date :

Application Number : 2187094

Regulatory Info : Prescription

Registration Country : Canada

blank

06

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

NORETHINDRONE

Brand Name : SYNPHASIC 21 TABLETS

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 21-PACK

Approval Date :

Application Number : 2187108

Regulatory Info : Prescription

Registration Country : Canada

blank

07

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

NORETHINDRONE

Brand Name : SYNPHASIC 21 TABLETS

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging : 21-PACK

Approval Date :

Application Number : 2187108

Regulatory Info : Prescription

Registration Country : Canada

blank

08

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

NORETHINDRONE

Brand Name : SYNPHASIC 28 TABLETS

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 28

Approval Date :

Application Number : 2187116

Regulatory Info : Prescription

Registration Country : Canada

blank

09

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

NORETHINDRONE

Brand Name : SYNPHASIC 28 TABLETS

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging : 28

Approval Date :

Application Number : 2187116

Regulatory Info : Prescription

Registration Country : Canada

blank

10

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

NORETHINDRONE

Brand Name : BREVICON 0.5/35 TABLETS (21-DAY PACK)

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 21

Approval Date :

Application Number : 2187086

Regulatory Info : Prescription

Registration Country : Canada

blank